On December 4, Endocrine Society hosted a meeting of the Diabetes Advocacy Alliance (DAA) to discuss recent legislative and regulatory advances in diabetes and how to achieve greater success through our collective work. Former Senate Majority Leader, Tom Daschle (pictured), provided a unique perspective at this meeting on opportunities to affect change in the 114th Congress, remarking that Democrats and Republicans will likely be further polarized but that there are several potential areas for bipartisanship. These issues include the repeal of the flawed sustainable growth rate formula, reimbursement for telehealth, and extending coverage of the National Diabetes Prevention Program to the Medicare population. The Society looks forward to continuing to advocate on behalf of these important issues and in working with the DAA to affect change together.
You may also like
Endocrine Society Advocacy Updates
Endocrine Society Endorses Right to IVF Act In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…
August 2024 Endocrine Society Advocacy Update
Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…
Loading ...